Singapore markets closed

  • Straits Times Index

    2,996.59
    +22.72 (+0.76%)
     

  • S&P 500

    3,870.29
    -31.53 (-0.81%)
     

  • Dow

    31,391.52
    -143.99 (-0.46%)
     

  • Nasdaq

    13,358.79
    0.00 (0.00%)
     

  • BTC-USD

    50,945.66
    +2,451.55 (+5.06%)
     

  • CMC Crypto 200

    1,020.37
    +32.28 (+3.27%)
     

  • FTSE 100

    6,695.88
    +82.13 (+1.24%)
     

  • Gold

    1,725.30
    -8.30 (-0.48%)
     

  • Crude Oil

    59.75
    0.00 (0.00%)
     

  • 10-Yr Bond

    1.4150
    0.0000 (0.00%)
     

  • Nikkei

    29,559.10
    +150.93 (+0.51%)
     

  • Hang Seng

    29,880.42
    +784.56 (+2.70%)
     

  • FTSE Bursa Malaysia

    1,588.45
    +18.58 (+1.18%)
     

  • Jakarta Composite Index

    6,376.76
    +17.55 (+0.28%)
     

  • PSE Index

    6,942.76
    +23.22 (+0.34%)
     

Walter Susini Joins the Board of Kooling as Senior Advisor

·2-min read

Kooling, a technology start-up that helps leading businesses to reduce their impact on Climate Change, welcomes Walter Susini, Senior Vice President of Marketing EMEA at The Coca Cola Company, as Senior Advisor of the Board. He brings strategic marketing, branding and innovation experience to the business, gained in the largest and most successful companies worldwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210126006140/en/

Walter Susini (Photo: Business Wire)

Walter has inspired the world’s leading brands on the importance of purpose and stakeholder value in order to drive sustainable growth.

In his current role at The Coca-Cola Company, Walter is leading an ambitious transformation of its EMEA marketing and innovation agenda and capabilities. During his 28 years career he has been working in consultancy, marketing and advertising in four continents. He led the global creative strategy, content and design function at Unilever as VP of Global Marketing, after starting his career at JW Thompson in strategic planning.

Walter also has successful experience as an entrepreneur, founding and running his own branding and innovation consultant firm with offices in Brazil, Mexico and Argentina.

David Falconi, Founder and CEO of Kooling, said: "We could not be more excited to welcome Walter to the Kooling family. It’s striking how closely the values Walter promotes match the mission, vision and purpose of Kooling. I have full confidence he’ll bring invaluable insight and direction on how we support our stakeholders and fulfill our mission."

Walter Susini, SVP Marketing of The Coca Cola Company said: "In all my career I’ve always been a strong believer that being a good business is good for the business. When we talk about sustainable practices, companies need to be part of the solution as they have been part of the problem and Kooling is the perfect platform for those companies that want to have a positive impact on the planet."

About Kooling: Kooling uses Big Data and AI to empower every business to reduce its impact on Climate Change. In 2020, the UK Government invested in Kooling innovation with an R&D Grant. Kooling was founded in London in 2019.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210126006140/en/

Contacts

David Falconi | 020 7846 0119 | info@kooling.io

Latest stories

  • Persimmon optimistic about 2021 as profit takes a hit

    Persimmon is targeting a full return to 2019 levels of new home completions in 2022.

  • Kenya hails first vaccines as 'bazookas' against COVID-19

    Kenya welcomed the arrival of over a million doses of the AstraZeneca COVID-19 vaccine on Wednesday in its first batch under a global plan to ensure equitable distribution. "We have received ... machine guns, bazookas, and tanks to fight this war against COVID-19," Health Minister Mutahi Kagwe exulted as the doses arrived at Nairobi's main airport. Kenya, which has so far recorded 106,470 infections and 1,863 deaths from the virus, has seen a jump in the number of daily cases in the last two weeks.

  • Enento Group Plc - Managers' transactions - Stråhlman

    ENENTO GROUP PLC, STOCK EXCHANGE RELEASE ON 3 MARCH AT 11.05 A.M. EET Enento Group Plc - Managers' transactions - Stråhlman____________________________________________ Person subject to the notification requirementName: Stråhlman, ElinaPosition: Chief Financial OfficerIssuer: Enento Group PlcLEI: 743700EPLUWXE25HGM03 Notification type: INITIAL NOTIFICATIONReference number:743700EPLUWXE25HGM03_20210302134704_21____________________________________________ Transaction date: 2021-03-01Venue not applicableInstrument type: SHAREISIN: FI4000123195Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 1757 Unit price: 0.00 EUR Aggregated transactions(1): Volume: 1757 Volume weighted average price: 0.00 EUR ENENTO GROUP PLC For further information: Pia KatilaInvestor Relations ManagerTel. +358 10 270 7506 Distribution: Nasdaq Helsinki Major mediaenento.com/investors Enento Group is a Nordic knowledge company powering society with intelligence since 1905. We collect and transform data into intelligence and knowledge used in interactions between people, businesses and societies. Our digital services, data and information empower companies and consumers in their daily digital decision processes, as well as financial processes and sales and marketing processes. Approximately 425 people are working for Enento Group in Finland, Norway, Sweden and Denmark. The Group’s net sales for 2020 was 151,3 MEUR. Enento Group is listed on Nasdaq Helsinki with the trading code ENENTO.

  • Sterling steadies ahead of UK budget

    Sterling steadied against the dollar on Wednesday and gained against the euro ahead of the announcement of Britain's budget for the coming fiscal year, which is expected to prop up the economy as it prepares for a reopening from lockdowns. In a budget speech at 1230 GMT, finance minister Rishi Sunak will promise to do "whatever it takes", including a five-month extension of a huge jobs rescue plan, to steer the economy through what he hopes will be the final months of COVID restrictions. Sunak has already racked up Britain's highest borrowing since World War Two and he will turn to the bond markets again in his budget speech, saying the task of fixing the public finances will only begin once a recovery is in sight.

  • Poland Insurance Market Analysis and Forecasts to 2022, Featuring Aviva, Metlife, PZU Zycie S.A., Uniqa Tu S.A. and More

    Dublin, March 03, 2021 (GLOBE NEWSWIRE) -- The "Insurance Market in Poland 2020-2022, CEE Insurance Series" report has been added to ResearchAndMarkets.com's offering. The insurance market in Poland 2020-2022 is the latest full update of comprehensive publication on the insurance sector in Poland. It describes the present market structure and recent trends in the insurance market. It also provides short term estimates of the insurance premium for the years 2020-2022. By contrast, within life insurance, premium contracted by ~3% YoY, however, the fall was not directly connected to COVID-19 but rather, it was a continuation of a long-term declining trend in life insurance-based investment products suffering from increasingly restrictive regulations. Tighter regulations are also quoted among triggers of recently observed consolidation. A few new M&A deals were announced in 2020, including the withdrawal of AXA - to be acquired by Uniqa and Aegon to be purchased by VIG. Moreover, an even bigger transaction is in the cards for 2021 as Aviva considered disposing of its Polish business. The impact of COVID-19 on the insurance sector in Poland has been noticeable across various product classes e.g. falling premium in car insurance or growing premium in property/accident insurance. However, the overall effect on the sector can be assessed as close to neutral. Premium in the non-life segment remained flat in Q1-Q3 2020 if compared to the same period of the previous year.Key Topics Covered: 1. Macroeconomic Overview Poland - Overview and key factsPoland in Europe: Number of households vs. wealth, 2019Key macroeconomic indicators, 2015-2020FForeign trade statistics, C/A, FDI, 2015-2020FUnemployment and salaries/wages, 2015-2020FDisposable income in households and income distribution, 2015-2020F; Income distribution 2019Consumer confidence index evolution, Dec. 2013 - Oct.2020Warsaw Stock Exchange - Turnover, Market cap. and indexes, 2014-2019Banking assets evolution, 2015-Q1 2020 2. Insurance Market Insurance Markets in CEE - Size vs. growth matrix, 2017-2019Insurance premiums per capita & premiums/GDP penetration - CEE comparison, 2019Insurance gross premiums - Local insurers (life/non-life, in EUR), 2016-2020FInsurance gross premiums - Local insurers (life/non-life, in PLN), 2016-2020FTop 10 insurance groups in Poland by total premium written, 1H 2020 (taking into account recently announced M&A)Insurance market concentration and Herfindahl-Hirschman Index (life/non-life), 1H 2019 vs. 1H 2020Current and upcoming Insurance M&A transactions in Poland, 2018-2020Own funds for life and non-life insurers, 2016-1H 2020, SCR coverage ratios, 2017-2019Number of insurance agents by type and number of sales reps (OFWCA), 2017-2019Insurance - Regulatory institutionsPrivate health Insurance - Opportunity for insurers; Premium written, 2017-2020F 3. Non-Life Insurance Non-life insurance markets in CEE - Size vs. growth matrix, 2017-2019Non-life premiums per capita & premiums/GDP penetration - CEE comparison, 2019Non-life insurance gross and net premium evolution, 2016-2020FTop 10 non-life insurance players in Poland, 1H 2020Market shares of top non-life players evolution, 2017-1H 2020Non-life premium by client segment and insurance class (car insurance vs. other), 1H 2020Non-life premium by risk class, 2018-1H 2020Sales channels of non-life insurance, 2018-2019Non-life insurers results, technical and P&L accounts (waterfall chart), 2019Non-life insurance - Profitability tree, 2016-1H 2020Non-life insurance - Claims and expense ratio evolution, 2016-1H 2020Non-life insurance - Combined ratio and its elements, 2016-1H 2020Non-life insurance - Acquisition costs evolution, 2018-1H2020, acquisition cost ratios for top non-life insurers, 2019Network multi-agents: Unilink, CUK, Conditor, LGK , Asist, Arrant, DCU etc.Current legislative initiatives affecting insurance business in Poland, 2017/2019Car insurance - Premium and no. policies evolution, MTPL, Casco, 2016-1H 2020Car insurance - Top players in MTPL and in Casco, 2018-1H 2020Car insurance - Combined ratio and its elements, MTPL and in Casco, 2018-1H 2020Car insurance - Average premium per policy for Casco and TPL, 1Q2015-3Q2020 4. Life Insurance Life insurance markets in CEE - Size vs. growth matrix, 2017-2019Life premiums per capita & premiums/GDP penetration - CEE comparison, 2019Life insurance gross and net premiums evolution, 2016-2020ETop 10 life insurance players in Poland, 1H 2020Market shares of top life players evolution, 2017-1H 2020Life premium by insurance class and segment, 1H 2020Life premium by risk class evolution, 2018-1H 2020Life insurance technical reserves evolution and structure, 2017-1H 2020Sales channels of life insurance, 2018-2019Life insurers results, Technical and P&L accounts (waterfall chart), 2019Life insurance - profitability tree, 2016-1H 2020Life insurance - acquisition costs evolution, 2018-1H 2020, acquisition cost ratios for top life insurers, 2019 5. Bancassurance Bancassurance: Premium written by bank channel (life/non-life), 2017-2019,data by KNF vs. data by PIUBancassurance: Product/class split in bank channel (life/non-life), 3Q 2020Bancassurance: Sales of investment type life products other than unit-linked, 2016-2020FBancassurance: Comparison websites and online sales sites of banks - overview, 2020 6. Top Players' Profiles 7. Forecast Companies Mentioned Allianz Zycie Polska S.A.AvivaAviva Polska - Tunz S.A.Axa Tu S.A.,Benefia Tu S.A. Vienna Insurance GroupBenefia Tunz S.A. Vienna Insurance GroupCompensa Tunz S.A.Vienna Insurance GroupConcordia Polska TuwGenerali Tu S.A.Hdi Asekuracja Tu S.ALink4 Tu S.A.MetlifeMTU Moje Towarzystwo UbezpieczenNN Tunz S.A.PZU S.A.PZU Zycie S.A.Stu Ergo Hestia S.A.Stunz Ergo Hestia S.A.TU Allianz Polska S.A.TU Compensa S.A.TU Euler Hermes S.A.TU Europa S.A.Tuir Warta S.A.Tunz Europa S.A.Tunz Warta S.A.Uniqa Tu Na Zycie S.A.Uniqa Tu S.A. For more information about this report visit https://www.researchandmarkets.com/r/hs8k9s About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Telefónica Germany/O2 Selects MATRIXX Software for Next-Generation Monetization

    Telefónica Germany/O2 chooses MATRIXX Digital Commerce Platform to deliver 4G/5G/Fixed monetization as part of operator's new, lean IT architecture.

  • French business activity at three-month low in February - PMI

    French business activity fell to a three-month low in February, albeit not as much as initially thought, as COVID-19 restrictions weigh on the dominant service sector, a monthly survey showed on Wednesday. Data compiler IHS Markit said its Purchasing Managers' Index fell last month to 47.0 from 47.7 in January, better than an initial reading of 45.2 and bringing the index further away from the 50-point threshold dividing an expansion in activity from a contraction. IHS Markit's PMI sub-index for the service sector fell to 45.6 from 47.3, better than an initial reading of 43.6.

  • Ukraine COVID-19 hospitalisations rise to record as Chinese vaccine faces delay

    A record number of Ukrainians were taken to hospital with coronavirus over the past 24 hours, while the number of deaths remains consistently high, health ministry data show on Wednesday. Health Minister Maksym Stepanov said on Facebook 3,486 people were hospitalised in the past day, the highest number since the epidemic hit the country of 41 million last year. Stepanov said 7,235 new cases were registered over the past 24 hours with 185 deaths.

  • Washington Post Warns What Easing Texas COVID-19 Rules May Do To Rest Of The Country

    GOP Gov. Greg Abbott is “gambling with the health of his state and beyond,” the newspaper's editorial board warned in a scathing column.

  • Notice convening the NKT Annual General Meeting

    Company Announcement 3 March 2021 Announcement No. 3 Notice convening the NKT Annual General MeetingThe Annual General Meeting of NKT A/S will be held Thursday 25 March 2021 at 3.00 p.m. (CET). In light of COVID-19 and the Danish authorities’ measures to control the risk of infection with COVID-19, the Board of Directors has decided that the Annual General Meeting of NKT this year will be held as a fully electronic general meeting.This implies that the shareholders, instead of attending the General Meeting in person, can participate and exercise their shareholders’ rights at the Annual General Meeting electronically. Attached please find invitation and agenda with the full contents of proposals and exhibits, including overview of candidates for the Board of Directors. The Chairman’s report will be available at www.nkt.com/investors after the Annual General Meeting. The NKT 2020 Annual Report and Remuneration Report can be found and printed at www.nkt.com/investors. Contact Investor Relations: Michael Nass Nielsen, Head of Investor Relations, Tel: +45 2494 1654 Press: Pelle Fischer, External Communications Lead, Tel: +45 2223 5870 Attachments NKT notice to convene Annual General Meeting Candidates for the Board of Directors - 2021 Invitation - 2021-uk Proxy and postal vote - 2021 Agenda and proposals - 2021 Remuneration Policy 2021 - Appendix Remuneration Policy 2021 - Final

  • Arrival’s electric van is ready for testing in the US and UK

    Arrival's electric cargo van will pop up on streets in the UK and US from this summer.

  • Isis claims responsibility for attack that killed three female journalists in Afghanistan

    Isis claims it is behind attacks that saw four women gunned down while they were on their way home from their work at TV station

  • Neuronetics, Inc. (STIM) Q4 2020 Earnings Call Transcript

    Good morning, and thank you for joining us for Neuronetics' fourth-quarter 2020 conference call. Joining me on today's call are Neuronetics president and chief executive officer, Keith Sullivan; and chief financial officer, Steve Furlong.

  • Emma Hayes and Millie Bright delighted by Women’s Champions League expansion

    A third WSL side will have the opportunity to qualify for the Champions League next season

  • The climate crisis can't be solved by carbon accounting tricks

    The climate crisis can't be solved by carbon accounting tricksDisaster looms if big finance is allowed to game the carbon offsetting markets to achieve ‘net zero’ emissions Mark Carney, former governor of the Bank of England at the UN climate change conference in 2020. Photograph: Reuters

  • Acts of Desperation by Megan Nolan review – learning to say no

    Acts of Desperation by Megan Nolan review – learning to say noA young Irish woman looks back on a toxic relationship in an impressive first novel with a niggling strand of moralism Megan Nolan ‘captures an intense experience with clarity and style’. Photograph: Linda Nylind/The Guardian

  • Enento Group Plc - Managers' transactions - Ruuska

    ENENTO GROUP PLC, STOCK EXCHANGE RELEASE ON 3 MARCH 2021 AT 11.00 A.M. EET Enento Group Plc - Managers' transactions - Ruuska ____________________________________________ Person subject to the notification requirementName: Ruuska, JukkaPosition: Chief Executive OfficerIssuer: Enento Group PlcLEI: 743700EPLUWXE25HGM03 Notification type: INITIAL NOTIFICATIONReference number: 743700EPLUWXE25HGM03_20210302134703_20____________________________________________ Transaction date: 2021-03-01Venue not applicableInstrument type: SHAREISIN: FI4000123195Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 4740 Unit price: 0.00 EUR Aggregated transactions(1): Volume: 4740 Volume weighted average price: 0.00 EUR ENENTO GROUP PLC For further information: Pia KatilaInvestor Relations ManagerTel. +358 10 270 7506 Distribution: Nasdaq Helsinki Major mediaenento.com/investors Enento Group is a Nordic knowledge company powering society with intelligence since 1905. We collect and transform data into intelligence and knowledge used in interactions between people, businesses and societies. Our digital services, data and information empower companies and consumers in their daily digital decision processes, as well as financial processes and sales and marketing processes. Approximately 425 people are working for Enento Group in Finland, Norway, Sweden and Denmark. The Group’s net sales for 2020 was 151,3 MEUR. Enento Group is listed on Nasdaq Helsinki with the trading code ENENTO.

  • Socially Responsible Investment at the Heart of CIP Saint Lucia Covid-19 Relief Bond innovation

    CIP St Lucia's Covid-19 Relief Bond innovation is arguably the only socially responsible investing (SRI) option in the investment migration industry.

  • Hexatronic resolves on new issue in kind for the acquisition of TK-KONTOR-FREITAG GmbH

    Hexatronic Group AB (publ) 556168-6360 Press Release March 3, 2021 Hexatronic resolves on new issue in kind for the acquisition of TK-KONTOR-FREITAG GmbH The Board of Directors of Hexatronic Group AB (publ) (“Hexatronic” or the “Company”) has resolved, pursuant to the authorisation granted by the annual general meeting on 7 May 2020, on an issue in kind of 90,357 ordinary shares in Hexatronic. The resolution has been adopted in accordance with the share purchase agreement which the Company has entered into for the acquisition of 75 percent of the shares in TK-KONTOR-FREITAG GmbH (“TK”), which was previously announced on 1 March 2021. The right to subscribe for the ordinary shares shall, pursuant to the share purchase agreement and the board resolution, only vest with the seller of TK and payment shall be made by the seller contributing in kind 75 percent of the shares in TK. The subscription price, which amounts to SEK 100.52 per share, corresponds to the average closing price for Hexatronic’s ordinary share on Nasdaq Stockholm during 30 days of trading before 1 March 2021. Through the new share issue, Hexatronic’s share capital increases by SEK 4,517.85 to SEK 1,905,589.05. The number of shares will after the new issue amount to 38,111,787, of which 37,751,787 are ordinary shares and 360,000 are shares of series C. The number of votes will, after the new issue, amount to 37,787,787. Gothenburg, March 3, 2021 Henrik Larsson Lyon CEO Hexatronic Group For more information, please contact: Henrik Larsson Lyon, CEO Hexatronic Group, +46 706 50 34 00 The information was submitted for publication, through the agency of the contact person set out above, at 10.00 CET on 3 March 2021. Hexatronic Group AB (publ) is a group that develops, markets and delivers products, components and system solutions with the main focus on the fiber optic market. Hexatronic offers a wide range of innovative system and product solutions mainly for passive fiber optic infrastructure with global trademarks like Matrix, Viper, Stingray, Raptor, InOne, Drytech™, Lightmate®, Skyline and Wistom®. The Group has its headquarters in Gothenburg, Sweden and has sales offices and/or subsidiaries in Sweden, Norway, Denmark, Finland, United Kingdom, Italy, Estonia, Latvia, Lithuania, Germany, China, New Zealand, US and Canada. The Group is listed on Nasdaq Stockholm under the ticker HTRO. For more information, visit www.hexatronicgroup.com. Attachment 2021-03-03 Hexatronic resolves on new issue

  • Zealand Pharma Hosts Conference Call on March 11 at 4 pm CET (10am ET) to Present Full Year Results for 2020

    Company announcement – No. 9 / 2021 Zealand Pharma Hosts Conference Call on March 11 at 4 pm CET (10am ET) to Present Full Year Results for 2020 Copenhagen, DK March 3, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that it will host a conference call on March 11, 2021 at 4 pm CET (10 am ET) following the announcement of results for the full year of 2020. Presenting during the call will be President and Chief Executive Officer Emmanuel Dulac, Senior Vice President and Chief Financial Officer Matt Dallas, and Executive Vice President and Chief Medical Officer Adam Steensberg. The presentation will be followed by a Q&A session. The conference call will be conducted in English, and the dial-in numbers are: Denmark, Copenhagen.................. +45 32 720 417Denmark, tollfree......................... +80 711 246France, Paris................................+33 (0) 170 700 781Netherlands, Amsterdam...............+31 (0) 207 956 614United Kingdom........................... +44 (0) 844 481 9752United States..............................+1 646 741 3167International .............................+44 (0) 2071 928338Confirmation Code: ...................... 3077735 A live audio webcast of the call, including an accompanying slide presentation, will be available via the following link, https://edge.media-server.com/mmc/p/7daetm5k, and will be accessible on the Investor section of Zealand’s website (www.zealandpharma.com/investor). Due to increased demand of conference call services, it could take longer to be connected to the call. Participants are advised to register for the webcast 30 minutes before the scheduled start, if possible. A recording of the event and a transcript will be available on the Investor section of Zealand’s website after the call. # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand’s robust pipeline of investigational medicines includes three candidates in late stage development, and one candidate being reviewed for regulatory approval in the United States. Zealand markets V-Go®, an all-in-one basal-bolus insulin delivery option for people with diabetes. License collaborations with Boehringer Ingelheim and Alexion Pharmaceuticals create opportunity for more patients to potentially benefit from Zealand-invented peptide therapeutics.Zealand was founded in 1998 in Copenhagen, Denmark, and has presence throughout the U.S. that includes key locations in New York, Boston, and Marlborough (MA). For more information about Zealand’s business and activities, please visit www.zealandpharma.com. Forward-Looking StatementsThis announcement may contain forward-looking statements, including “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, that are based on the beliefs and assumptions and on information currently available to management of Zealand, including with respect to the closing of the Offering described herein. All statements other than statements of historical fact contained in this announcement are forward-looking statements, including statements regarding the anticipated final terms of the Investment. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Zealand's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the "Risk Factors" section of the Zealand's Annual Report on Form 20-F for the year ended December 31, 2019 filed with the SEC on March 13, 2020 and subsequent reports that Zealand filed or files with the SEC. Forward-looking statements represent Zealand's beliefs and assumptions only as of the date of this announcement. Although Zealand believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, levels of activity, performance or achievements. Except as required by law, Zealand assumes no obligation to publicly update any forward‐looking statements for any reason after the date of this announcement to conform any of the forward-looking statements to actual results or to changes in its expectations. For further information, please contact: Zealand Pharma Investor RelationsMaeve ConneightonArgot Partners investors@zealandpharma.com Zealand Pharma Media Relations David Rosen Argot Partnersmedia@zealandpharma.com